Delivery Order SPE2DB20D3111-SPE2DB25FA6QH

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,055.03 firm fixed-price delivery order is for RECTIV 0.4% ointment, 30 gram tubes. The contract has an ultimate completion date of January 16, 2025 and is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of RECTIV 0.4% OINTMENT 30GM. The $1,675.94 firm fixed-price delivery order contract has a completion date of February 7, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is a delivery order (SPE2DB20D1100|SPE2DB25FA2K1) worth $4,618.10 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide RECTIV 0.4% ointment, a medical product, to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,595.11, is a Firm Fixed Price Delivery Order to provide medical supplies and pharmaceuticals, including the product "RECTIV 0.4% OINT 1S". The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $1,415.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a delivery order for the supply of "RECTIV 0.4% OINTMENT 30GM" medical products. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $5,340.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RECTIV 0.4% ointment, a medical product, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for $1,027.22 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) for the delivery of "RECTIV 0.4% OINTMENT 30GM" medical supplies. The contract is a Firm Fixed Price Delivery Order with a performance period through January 14, 2025. No set-aside designation was used for this award. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical with a firm fixed price of $1,707.85 and a completion date of March 1, 2024. The contract is for the supply of RECTIV 0.4% ointment in 30 gram packages. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product, RECTIV 0.4% Ointment 30GM. The $3,705.96 contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support...
This contract award to Amerisourcebergen Drug Corp is for the supply of a pharmaceutical product, specifically RECTIV 0.4% OINTMENT 30GM, to the Defense Logistics Agency (DLA). The $1,434.09 fixed-price delivery order has a completion date of December 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA6QH
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,383.58 Firm Fixed Price Delivery Order is for the supply of 4567114793 RECTIV 0.4% OINTMENT 30GM medical products. The award is not designated under any set-aside program.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award represents a task order or delivery order placed against that larger IDC. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/2/25, 10:00 AM